WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 10-December-2019 (data as of 10-December-2019)
Next overall update June 2020
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'9601 Infant (under 12 months) mortality rate: 652
GDP / capita (US$): 5'9801 Child (under 5 years) mortality rate: 1002

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 195'875  190'873  185'960  181'137  176'405  122'284  95'212  73'424 
Births 7'433  7'334  7'236  7'137  7'035  5'288  4'217  3'439 
Surviving infants 6'977  6'869  6'761  6'651  6'537  4'697  3'683  2'997 
Pop. less than 5 years 32'917  32'412  31'831  31'132  30'479  21'074  16'799  13'367 
Pop. less than 15 years 85'924  84'009  82'020  79'937  77'969  53'321  42'821  32'353 
Female 15-49 years 91'087  88'519  86'085  83'809  81'502  56'608  42'600  33'416 

Number of reported cases

(Click for retrospective incidence data for Nigeria)
Diphtheria
ChartChart
  1'870  3'995  1'768  165 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  7'063  11'190  17'136  12'423  6'855  212'183  115'682  162'106 
Mumps
ChartChart
 
Pertussis
ChartChart
  7'897  4'244  6'592  9'559  38'910  42'929  48'996 
Polio*
ChartChart
  34  36  638  1'873  816 
Rubella
ChartChart
  4'772  543  503  419  102 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  130  187  34  53  104  1'643  1'060 
Tetanus (total)**
ChartChart
  131  187  34  53  208  1'643  2'703  3'095 
Yellow fever
ChartChart
  47  26  4'075 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nigeria)
Vaccine year result method % card seen                                                
BCG 2015  53  MICS   29  75  53  58  58  73  34  80 
DTP1 2016  70  EPI   40  72  49  55  55  76  48 
DTP3 2016  57  EPI   40  58  33  45  45  70  38  56 
IPV1          93  99*  45  45 
HepB_BD          63  30  36  35  54 
HepB3 2016  57  EPI   40  58  33  45  45  70 
Hib3 2016  57  EPI   40  58  33  70 
JapEnc         
MCV1          63  42  43  43  73  30  48 
MCV2         
MenA         
PCV1          72  99*  44  44 
PCV2          64  95  35  35 
PCV3 2015  27  MICS   29  58  99*  29  29 
Pol3 2015  35  MICS   29  58  33  37  37  72  38  55 
Rota1         
RotaC         
RCV1         
TT2plus 2015  48  MICS   29  62  60  47  40  44  56 
PAB          48 
VAD1          19  13  16 
YFV 2015  39  MICS   29  61  39  41  41  71 
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nigeria)
BCG
ChartChart
  53  53  58  58  51  44  80 
DTP1
ChartChart
  70  70  70  55  48  42  79 
DTP3
ChartChart
  57  57  57  45  43  29  56 
HepB3
ChartChart
  57  57  57  42  43 
HepB_BD
ChartChart
 
Hib3
ChartChart
  57  57  57  42  43 
IPV1
  57  57  57  45 
MCV1
ChartChart
  65  65  65  43  44  33  54 
MCV2
 
PCV3
ChartChart
  57  57  57  36 
Pol3
ChartChart
  57  57  57  40  50  31  55 
RCV1
 
RotaC
 
YFV
ChartChart
  65  65  65  41  49 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 774  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 18
From 50 to 79% 23
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 week; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric 1 week; Yes
HPV Yes from September 2020; 9-18 year old females
IPV 14 weeks; Yes
Measles 9 months; Yes 2nd dose at 15 months planned for introduction in Oct 2019
MenA_conj 9 months; Yes from June 2019
OPV 1, 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes from October 2019
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes 5% of total popualation
VitaminA 6, 12 months; Yes
YF 14 weeks; Yes

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2018-2028  2016-2020  2016-2020  2016-2020  2011-2015  2011-2015  2011- 2015 
Nº of districts with microplans that include activities to raise immunization coverage number 772  774  772  761  705  774  774 

System performance

Total Nº districts in country number 774  774  774  774  774  774  774 
Nº districts with DTP3 coverage >=80% number 579  684  537  616  616  554  117 
% of districts with DTP3 coverage >=80% From 0 to 100% 75  88  69  80  80  72  15 
Nº districts with measles (MCV1) coverage >=95% number 283  457  430  402  409  393  192 
% of districts with MCV1 coverage >=95% From 0 to 100% 37  59  56  52  53  51  25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 26  24  29  40  24     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  Yes 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.